Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v4-FR
Language French French
Date Updated 2020-06-10 2017-05-12
Drug Identification Number 02309769 02309769
Brand name PMS-LOSARTAN PMS-LOSARTAN
Common or Proper name LOSARTAN LOSARTAN
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients LOSARTAN POTASSIUM LOSARTAN POTASSIUM
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-09-25 2017-09-06
Actual start date 2017-09-25
Estimated end date Unknown 2018-01-10
Actual end date 2020-06-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Format discontinued
Health Canada comments